JNJ
Johnson & Johnson NYSE Listed Jan 2, 1943$222.47
Mkt Cap $535.5B
52w Low $146.12
72.3% of range
52w High $251.71
50d MA $237.31
200d MA $207.19
P/E (TTM)
20.6x
EV/EBITDA
13.0x
P/B
6.8x
Debt/Equity
0.6x
ROE
25.9%
P/FCF
25.6x
RSI (14)
—
ATR (14)
—
Beta
0.33
50d MA
$237.31
200d MA
$207.19
Avg Volume
8.3M
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
One Johnson & Johnson Plaza · New Brunswick, NJ 08933 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 14, 2026 | AMC | 2.68 | 2.70 | +0.7% | 240.10 | -0.1% | -0.6% | -2.3% | -2.5% | -3.9% | -5.8% | — |
| Jan 21, 2026 | AMC | 2.46 | 2.46 | +0.0% | 218.01 | +0.3% | +0.2% | +1.0% | +1.6% | +2.9% | +4.5% | — |
| Oct 14, 2025 | AMC | 2.76 | 2.80 | +1.4% | 190.85 | +0.3% | +0.2% | +0.7% | +1.2% | +1.5% | +0.5% | — |
| Jul 16, 2025 | AMC | 2.68 | 2.77 | +3.4% | 164.78 | -1.0% | -1.1% | -0.7% | -0.3% | +1.9% | +2.6% | — |
| Apr 15, 2025 | AMC | 2.58 | 2.77 | +7.4% | 153.62 | +1.1% | +0.2% | +2.5% | +2.1% | +2.7% | +1.1% | — |
| Jan 22, 2025 | AMC | 1.99 | 2.04 | +2.5% | 145.27 | +0.1% | +0.9% | +1.1% | +5.3% | +3.5% | +4.0% | — |
| Oct 15, 2024 | AMC | 2.21 | 2.42 | +9.5% | 164.10 | -0.1% | +0.1% | +0.2% | +0.6% | -0.8% | -0.4% | — |
| Jul 17, 2024 | AMC | 2.71 | 2.82 | +4.1% | 156.58 | -0.6% | -0.7% | -1.2% | -1.5% | -2.7% | -0.2% | — |
| Apr 16, 2024 | AMC | 2.64 | 2.71 | +2.7% | 144.45 | +0.4% | +0.2% | +0.9% | +2.4% | +3.2% | +3.5% | — |
| Jan 23, 2024 | AMC | 2.27 | 2.29 | +0.9% | 159.81 | -0.0% | -0.5% | -0.2% | -0.2% | -0.3% | -0.7% | — |
| Oct 17, 2023 | AMC | 2.52 | 2.66 | +5.6% | 156.09 | -0.4% | -2.2% | -2.4% | -2.0% | -3.0% | -3.1% | — |
| Jul 20, 2023 | AMC | 2.61 | 2.80 | +7.3% | 168.38 | -0.1% | +1.1% | +1.6% | +2.4% | +2.6% | +3.2% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15 | Barclays | Maintains | Equal Weight → Equal Weight | — | $240.10 | $239.94 | -0.1% | -0.6% | -2.3% | -2.5% | -3.9% | -5.8% |
| Apr 15 | Wells Fargo | Maintains | Overweight → Overweight | — | $240.10 | $239.94 | -0.1% | -0.6% | -2.3% | -2.5% | -3.9% | -5.8% |
| Apr 15 | Stifel | Maintains | Hold → Hold | — | $240.10 | $239.94 | -0.1% | -0.6% | -2.3% | -2.5% | -3.9% | -5.8% |
| Apr 10 | Morgan Stanley | Maintains | Overweight → Overweight | — | $241.31 | $242.00 | +0.3% | -1.2% | -1.4% | -0.5% | -1.1% | -2.8% |
| Mar 30 | RBC Capital | Maintains | Outperform → Outperform | — | $240.45 | $243.49 | +1.3% | +0.8% | +1.7% | +1.5% | +1.1% | +0.2% |
| Mar 19 | Barclays | Maintains | Equal Weight → Equal Weight | — | $237.28 | $238.34 | +0.4% | +0.1% | -0.8% | -0.8% | -0.8% | +1.1% |
| Mar 17 | HSBC | Maintains | Buy → Buy | — | $243.19 | $243.58 | +0.2% | -2.1% | -2.4% | -2.3% | -3.2% | -3.2% |
| Mar 11 | Citigroup | Maintains | Buy → Buy | — | $243.71 | $242.87 | -0.3% | -0.3% | -0.7% | -0.9% | -0.2% | -2.3% |
| Mar 5 | JP Morgan | Maintains | Neutral → Neutral | — | $245.30 | $242.63 | -1.1% | -2.3% | -2.0% | -1.1% | -0.6% | -0.9% |
| Feb 3 | RBC Capital | Maintains | Outperform → Outperform | — | $230.75 | $231.50 | +0.3% | +1.0% | +1.6% | +3.1% | +4.0% | +3.4% |
| Jan 28 | Morgan Stanley | Upgrade | Equal Weight → Overweight | — | $224.44 | $226.40 | +0.9% | +1.5% | +1.3% | +1.3% | +2.8% | +3.9% |
| Jan 27 | Freedom Capital Markets | Maintains | Hold → Hold | — | $221.49 | $222.00 | +0.2% | +1.3% | +2.8% | +2.6% | +2.6% | +4.2% |
| Jan 27 | Freedom Broker | Maintains | Hold → Hold | — | $221.49 | $222.00 | +0.2% | +1.3% | +2.8% | +2.6% | +2.6% | +4.2% |
| Jan 23 | Guggenheim | Maintains | Buy → Buy | — | $218.49 | $219.80 | +0.6% | +0.8% | +1.4% | +2.7% | +4.2% | +4.0% |
| Jan 22 | Scotiabank | Maintains | Sector Outperform → Sector Outperform | — | $218.01 | $218.77 | +0.3% | +0.2% | +1.0% | +1.6% | +2.9% | +4.5% |
| Jan 22 | Wells Fargo | Maintains | Overweight → Overweight | — | $218.01 | $218.77 | +0.3% | +0.2% | +1.0% | +1.6% | +2.9% | +4.5% |
| Jan 22 | Citigroup | Maintains | Buy → Buy | — | $218.01 | $218.77 | +0.3% | +0.2% | +1.0% | +1.6% | +2.9% | +4.5% |
| Jan 22 | TD Cowen | Maintains | Buy → Buy | — | $218.01 | $218.77 | +0.3% | +0.2% | +1.0% | +1.6% | +2.9% | +4.5% |
| Jan 22 | BofA Securities | Maintains | Neutral → Neutral | — | $218.01 | $218.77 | +0.3% | +0.2% | +1.0% | +1.6% | +2.9% | +4.5% |
| Jan 22 | Stifel | Maintains | Hold → Hold | — | $218.01 | $218.77 | +0.3% | +0.2% | +1.0% | +1.6% | +2.9% | +4.5% |
| Jan 22 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $218.01 | $218.77 | +0.3% | +0.2% | +1.0% | +1.6% | +2.9% | +4.5% |
| Jan 9 | Bernstein | Maintains | Market Perform → Market Perform | — | $205.75 | $205.91 | +0.1% | -0.7% | +1.9% | +3.8% | +6.2% | +6.7% |
| Dec 30 | Barclays | Maintains | Equal Weight → Equal Weight | — | $207.56 | $207.51 | -0.0% | -0.3% | -0.3% | -0.1% | -1.6% | -1.3% |
| Dec 19 | Goldman Sachs | Maintains | Buy → Buy | — | $208.31 | $207.56 | -0.4% | -0.9% | -0.5% | -1.2% | -0.3% | -0.3% |
| Dec 15 | BofA Securities | Maintains | Neutral → Neutral | — | $211.58 | $210.35 | -0.6% | +1.2% | -1.1% | -0.6% | -1.5% | -2.5% |
| Dec 12 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $210.01 | $210.28 | +0.1% | +0.7% | +2.0% | -0.3% | +0.2% | -0.8% |
| Dec 11 | RBC Capital | Maintains | Outperform → Outperform | — | $206.54 | $207.90 | +0.7% | +1.7% | +2.4% | +3.7% | +1.3% | +1.8% |
| Dec 11 | Citigroup | Maintains | Buy → Buy | — | $206.54 | $207.90 | +0.7% | +1.7% | +2.4% | +3.7% | +1.3% | +1.8% |
| Dec 5 | Guggenheim | Maintains | Buy → Buy | — | $202.48 | $202.98 | +0.2% | -0.3% | -0.4% | -1.2% | +2.0% | +3.7% |
| Dec 2 | Barclays | Maintains | Equal Weight → Equal Weight | — | $205.34 | $205.24 | -0.0% | +0.0% | -0.0% | -1.4% | -1.7% | -1.8% |
| Oct 22 | Freedom Capital Markets | Downgrade | Buy → Hold | — | $191.88 | $192.00 | +0.1% | +0.6% | +0.3% | -0.8% | -0.8% | -2.6% |
| Oct 22 | Freedom Broker | Downgrade | Buy → Hold | — | $191.88 | $192.00 | +0.1% | +0.6% | +0.3% | -0.8% | -0.8% | -2.6% |
| Oct 15 | Raymond James | Maintains | Outperform → Outperform | — | $190.85 | $191.48 | +0.3% | +0.2% | +0.7% | +1.2% | +1.5% | +0.5% |
| Oct 15 | BofA Securities | Maintains | Neutral → Neutral | — | $190.85 | $191.48 | +0.3% | +0.2% | +0.7% | +1.2% | +1.5% | +0.5% |
| Oct 15 | Citigroup | Maintains | Buy → Buy | — | $190.85 | $191.48 | +0.3% | +0.2% | +0.7% | +1.2% | +1.5% | +0.5% |
| Oct 15 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $190.85 | $191.48 | +0.3% | +0.2% | +0.7% | +1.2% | +1.5% | +0.5% |
| Oct 15 | Stifel | Maintains | Hold → Hold | — | $190.85 | $191.48 | +0.3% | +0.2% | +0.7% | +1.2% | +1.5% | +0.5% |
| Oct 14 | UBS | Maintains | Buy → Buy | — | $190.90 | $192.92 | +1.1% | -0.0% | +0.1% | +0.6% | +1.2% | +1.5% |
| Oct 10 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $191.08 | $192.01 | +0.5% | -0.2% | -0.1% | -0.1% | +0.0% | +0.5% |
| Oct 9 | Goldman Sachs | Maintains | Buy → Buy | — | $189.69 | $190.00 | +0.2% | +0.7% | +0.5% | +0.6% | +0.6% | +0.8% |
| Oct 7 | Citigroup | Maintains | Buy → Buy | — | $188.16 | $183.77 | -2.3% | +0.4% | +0.8% | +1.6% | +1.4% | +1.5% |
| Oct 6 | Bernstein | Maintains | Market Perform → Market Perform | — | $188.64 | $188.00 | -0.3% | -0.3% | +0.1% | +0.6% | +1.3% | +1.1% |
| Oct 3 | BofA Securities | Maintains | Neutral → Neutral | — | $185.98 | $187.06 | +0.6% | +1.4% | +1.2% | +1.6% | +2.0% | +2.7% |
| Oct 3 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $185.98 | $187.06 | +0.6% | +1.4% | +1.2% | +1.6% | +2.0% | +2.7% |
| Sep 23 | Guggenheim | Upgrade | Neutral → Buy | — | $174.21 | $174.89 | +0.4% | +1.4% | +1.4% | +2.0% | +3.2% | +4.3% |
| Sep 16 | JP Morgan | Maintains | Neutral → Neutral | — | $177.40 | $177.57 | +0.1% | -0.5% | -0.1% | -1.8% | -0.7% | -1.8% |
| Aug 21 | Citigroup | Maintains | Buy → Buy | — | $178.84 | $178.55 | -0.2% | +0.1% | +0.3% | -0.2% | -1.3% | -1.1% |
| Jul 17 | Guggenheim | Maintains | Neutral → Neutral | — | $164.78 | $163.18 | -1.0% | -1.1% | -0.7% | -0.3% | +1.9% | +2.6% |
| Jul 17 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $164.78 | $163.18 | -1.0% | -1.1% | -0.7% | -0.3% | +1.9% | +2.6% |
| Jul 17 | BofA Securities | Maintains | Neutral → Neutral | — | $164.78 | $163.18 | -1.0% | -1.1% | -0.7% | -0.3% | +1.9% | +2.6% |
No insider trades available.
8-K
Johnson & Johnson -- 8-K Filing
Johnson & Johnson shareholders rejected a proposal requiring an independent board chair while reelecting their auditor, maintaining current governance structure.
Apr 28
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
Johnson & Johnson reported Q1 2026 earnings on April 14, 2026; investors should review the detailed financial results and sales data to assess whether the company met expectations and maintained growth momentum.
Apr 14
Data updated apr 24, 2026 9:57am
· Source: massive.com